Preclinical Drug Compound Request Program
The Takeda Preclinical Drug Compound Request Program supports investigator-initiated oncology research. As part of this program, we provide investigators with certain research and marketed compounds for eligible pre-clinical studies.
How does it work?
Prospective investigators submit their contact information and detailed study proposal to the Takeda Preclinical Drug Compound Request System. Our R&D teams review each proposal, and if the study is approved, a material transfer agreement is negotiated with the investigator's institution. Typically, the review process can take four to eight weeks from the time Takeda receives a proposal.
Application Process
Upon entering the Takeda Preclinical Drug Compound Request System, an investigator is asked to create a username and password.
Once in the system, the applicant follows the prompts to provide contact information, names of any collaborators and lab interests. In Step 2, the applicant enters the goals of the study, the methods and materials (e.g. cell lines, models) to be used and the investigator's CV. When the submission is complete, applicants click the "submit" button and Takeda will begin the review process.
Investigators may track the status of requests by logging back into the Takeda Preclinical Drug Compound Request System at any time. Investigators are notified of Takeda Oncology's decision by email.
If selected, the investigator will be responsible for:
- Disclosing other relevant third party affiliations (collaborators, compounds, cell lines, models)
- Submitting twice yearly data/status updates
- Informing Takeda of any study related milestones or events
- Informing Takeda if the investigator transfers to a new institution
- Delivering any draft manuscripts based on the research according to the negotiated terms of the material transfer agreement
Interacting with Takeda Oncology on Social Media
Takeda Oncology recognizes the importance of social media channels in the communication space. However, in embracing these channels, we aim to engage responsibly. Below, we have outlined our current active channels as well as our terms and guidelines for interacting with us on these channels. Current channels in which Takeda Oncology participates:
Other services may be added. Check back occasionally to see all of the channels we support.
These channels were created and are managed by Takeda Oncology. Their purpose is to educate the public about our company, mission, values as well as the diseases we aspire to cure and the populations we serve. The content posted by Takeda Oncology is for informational and educational purposes only and is NOT intended to be a substitute for professional medical advice.
Mentions, comments, likes, favorites and retweets are welcomed! However, please note, the pharmaceutical industry is a highly regulated one and as a result we may not be allowed to respond to "@mentions" and replies that:
Please note that accounts that Takeda Oncology follows/interacts with or accounts that follow/interact with us on our various channels are not an indication of Takeda Oncology's endorsement of these accounts or the content they produce. Additionally, favorites, likes, comments and/or retweets do not indicate endorsement.
Takeda Oncology may provide links or references to other websites as part of its social content. We claim no responsibility for the accuracy or content of such other sites and shall not be liable for any damages or injury arising from that content.
Please do not use these channels to report adverse events or medical side effects. If you believe that you have experienced any medical side effects or reactions from a Takeda Oncology product you should consult your physician, pharmacist or other healthcare professional immediately. You can also report these to us directly by calling us here: 1-877-TAKEDA7.
We will do our best to answer your comments and questions; however, there may be some things we cannot address, such as questions directly related to financial, legal, regulatory, confidential information, or medical issues. In scenarios when Takeda Oncology cannot post or respond to your comment, we will send a private message to you explaining why.
Thank you for your interest in connecting with us on social media — we look forward to hearing from you and sharing more about our work in the fight against cancer.
DISCLAIMER
Takeda Oncology does not endorse any user or associated products and services of any social media user that interacts with our profiles. Takeda Oncology may link to an external website for interest or convenience. Takeda Oncology claims no responsibility for the content of sites over which we have no control, and are not liable for any damages or injury arising from that content. Takeda Oncology reserves all rights relating to our social media profiles and properties, including discontinuing the Page, removing unwanted connections, responding to any questions or comments, and removing or modifying any content posted to the profile.
Continue Cancel